An optimal mechanism to fund the development of vaccines against emerging epidemics

IF 3.4 2区 经济学 Q1 ECONOMICS
Christopher M. Snyder , Kendall Hoyt , Dimitrios Gouglas
{"title":"An optimal mechanism to fund the development of vaccines against emerging epidemics","authors":"Christopher M. Snyder ,&nbsp;Kendall Hoyt ,&nbsp;Dimitrios Gouglas","doi":"10.1016/j.jhealeco.2023.102795","DOIUrl":null,"url":null,"abstract":"<div><p><span>We derive the optimal funding mechanism to incentivize development and production of vaccines against diseases<span> with epidemic potential. In the model, suppliers’ costs are private information and investments are noncontractible, precluding cost-reimbursement contracts, requiring fixed-price contracts conditioned on delivery of a successful product. The high failure risk for individual vaccines calls for incentivizing multiple entrants, accomplished by the optimal mechanism, a </span></span><span><math><mrow><mo>(</mo><mi>w</mi><mo>+</mo><mn>1</mn><mo>)</mo></mrow></math></span>-price reverse Vickrey auction with reserve, where <span><math><mi>w</mi></math></span> is the number of selected entrants. Our analysis determines the optimal number of entrants and required funding level. Based on a distribution of supplier costs estimated from survey data, we simulate the optimal mechanism’s performance in scenarios ranging from a small outbreak, causing harm in the millions of dollars, to the Covid-19 pandemic, causing harm in the trillions. We assess which mechanism features contribute most to its optimality.</p></div>","PeriodicalId":50186,"journal":{"name":"Journal of Health Economics","volume":null,"pages":null},"PeriodicalIF":3.4000,"publicationDate":"2023-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Health Economics","FirstCategoryId":"96","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0167629623000723","RegionNum":2,"RegionCategory":"经济学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}
引用次数: 0

Abstract

We derive the optimal funding mechanism to incentivize development and production of vaccines against diseases with epidemic potential. In the model, suppliers’ costs are private information and investments are noncontractible, precluding cost-reimbursement contracts, requiring fixed-price contracts conditioned on delivery of a successful product. The high failure risk for individual vaccines calls for incentivizing multiple entrants, accomplished by the optimal mechanism, a (w+1)-price reverse Vickrey auction with reserve, where w is the number of selected entrants. Our analysis determines the optimal number of entrants and required funding level. Based on a distribution of supplier costs estimated from survey data, we simulate the optimal mechanism’s performance in scenarios ranging from a small outbreak, causing harm in the millions of dollars, to the Covid-19 pandemic, causing harm in the trillions. We assess which mechanism features contribute most to its optimality.

为开发新出现流行病的疫苗提供资金的最佳机制。
我们得出了最佳的资助机制,以激励针对具有流行病潜力的疾病的疫苗的开发和生产。在该模型中,供应商的成本是私人信息,投资是不可行的,排除了成本补偿合同,要求以成功交付产品为条件的固定价格合同。单个疫苗的高失败风险要求激励多个进入者,这是通过最优机制实现的,即(w+1)-价格的带储备的反向维克里拍卖,其中w是选定进入者的数量。我们的分析确定了进入者的最佳数量和所需资金水平。根据调查数据估计的供应商成本分布,我们模拟了最佳机制在从造成数百万美元伤害的小规模疫情到造成数万亿美元伤害的新冠肺炎大流行等场景中的表现。我们评估哪些机制特征对其最优性贡献最大。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Health Economics
Journal of Health Economics 医学-卫生保健
CiteScore
6.10
自引率
2.90%
发文量
96
审稿时长
49 days
期刊介绍: This journal seeks articles related to the economics of health and medical care. Its scope will include the following topics: Production and supply of health services; Demand and utilization of health services; Financing of health services; Determinants of health, including investments in health and risky health behaviors; Economic consequences of ill-health; Behavioral models of demanders, suppliers and other health care agencies; Evaluation of policy interventions that yield economic insights; Efficiency and distributional aspects of health policy; and such other topics as the Editors may deem appropriate.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信